NICE dementia pathway
This navigable pathway includes recommendations for the identification, treatment and care of people with dementia and the support of carers. Read more »
You are exploring: Diagnosing well
Torbay Local Enhanced Scheme 2011-12
This programme has helped practices to use examination of their patient register to identify patients with confusion or memory problems who might be in the early stages of dementia and/or whose condition may have deteriorated. Read more »
Technology appraisal TA217 Alzheimer's disease – donepezil, galantamine, rivastigmine and memantine
This guidance replaces NICE technology appraisal guidance 111 issued in November 2006 (amended September 2007, August 2009). Read more »
Map of Medicine for dementia assessment
The Map of Medicine for dementia assessment supports the identification and diagnosis of people living with dementia. Read more »
Guidance on the commissioning of memory assessment services
This guidance sets out specifications for a specialist memory assessment service for people with a possible or suspected diagnosis of dementia. Read more »
Prescribing review: Acetyl Cholinesterase inhibitors
This audit was undertaken by North Staffordshire Combined Healthcare NHS Trust to establish compliance with NICE Technology Appraisal Guidance 111 on the use of donepezil, galantamine and rivastigmine for the treatment of mild to moderately severe Alzheimer’s disease. Read more »
Somerset dementia strategy
Somerset dementia strategy provides a framework to implement improved, responsive and quality services for people with dementia and their carers across Somerset. The accompanying action plan outlines work underway to achieve the strategy objectives. Read more »
Late-onset dementia: early diagnosis and drug treatment
This video from SocialCareTV, managed by the Social Care Institute for Excellence, illustrates the positive effects of an early diagnosis of dementia and the crucial support role carers can play. Read more »
Prescribing guidelines: Acetyl Cholinesterase inhibitors
These prescribing guidelines developed by Berkshire Healthcare NHS Foundation Trust support GPs on the use of Acetyl Cholinesterase inhibitors (ChEIs) for the treatment of Alzheimer’s dementia in accordance with NICE guidance. Read more »
Counting the cost: caring for people with dementia on hospital wards
This report provides evidence on the quality of dementia care provided on general wards in hospitals across England, Wales and Northern Ireland. Using evidence received from carers and nurses on the quality of care provided the key areas of need that are not being met are discussed. These include: understanding dementia the provision of person-centred… Read more »